ERS/French Programme I

Session
Chairs: Elisabeth H.D. Bel (Amsterdam, Netherlands), Philippe Delaval (Cesson-Sevigne, France)
Aims: The aim of this session is to provide an updated overview of new therapeutics in various fields of respiratory medicine. Future drugs and strategies that might develop within the next 5 years will also be presented and discussed by internationally recognised experts. Note that the presentations will be conducted in French with dual projection of slides in French and English.
Target audience: Clinician

Réduction volumique par spirales dans le traitement de l’emphysème sévèreLung reduction coil treatment in severe emphysema Gaëtan Deslee (Reims, France)
Médecine personnalisée et BPCO: où en sommes-nous ?Personalised medicine and COPD: where are we now? Nicolas Roche (Paris, France)
Syndrome obésité-hypoventilation: de la physiologie au traitementObesity hypoventilation: from pathophysiology to treatment Jean-Paul Janssens (Geneva, Switzerland)